- Advertisement -
- Advertisement -

Related

Rhenman & Partners Strengthening Their Ranks

Latest Report

- Advertisement -

Stockholm (HedgeNordic) – Rhenman & Partners is expanding its portfolio management team with the addition of Camilla Oxhamre Cruse as the fourth portfolio manager, with a primary focus on pharmaceutical development companies. Starting in early September, Cruse will join the four-member investment team led by founder and CIO Henrik Rhenman.

Cruse has spent the last ten years in London, most recently as a senior healthcare analyst and assistant portfolio manager at Newton Investment Management. Her career also includes a seven-and-a-half-year tenure at William Blair & Company as a senior research analyst covering the global healthcare sector. Prior to her time in London, Cruse was a senior equity analyst at Carnegie Investment Bank in Stockholm, focusing on healthcare. She holds a master’s degree in biochemistry from Lund University, a doctorate in medicine from Karolinska Institute, and an MBA from Hawaii Pacific University in the United States.

“Camilla’s long international background and broad expertise in the medical field and her experience in the financial markets will be a strong addition to our organization.”

Henrik Rhenman, founder and CIO at Rhenman & Partners.

“We are very pleased that Camilla will become part of Rhenman & Partners,” says Henrik Rhenman, founder and CIO at Rhenman & Partners. “Camilla’s long international background and broad expertise in the medical field and her experience in the financial markets will be a strong addition to our organization,” he continues. “Camilla will work closely with the entire investment team, focusing on the biotech and pharmaceutical sub-sectors where we continue to see great potential.” 

“It is a company that I have followed for a long time and that has impressed me with its in-depth fundamental analysis in the healthcare sector, integrity and skillful management, which has led to a long track record of positive returns.”

Camilla Oxhamre Cruse

“I look forward to joining Rhenman & Partners,” comments Camilla Oxhamre Cruse. “It is a company that I have followed for a long time and that has impressed me with its in-depth fundamental analysis in the healthcare sector, integrity and skillful management, which has led to a long track record of positive returns,” she adds. “I am really pleased to become part of the team and to be able to contribute with my many years of analytical experience of the global pharmaceutical sector.”

Cruse will work alongside portfolio managers Kaspar Hållsten, Hugo Schmidt, and Amennai Beyeen, under the leadership of CIO Henrik Rhenman, to manage the Rhenman Healthcare Equity L/S fund. Since its launch in mid-2009, the fund has delivered an annualized return of 16.6 percent for the share class represented in the Nordic Hedge Index. The fund has gained 17.1 percent in the first seven months of 2024.

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Eugeniu Guzun
Eugeniu Guzun
Eugeniu Guzun serves as a data analyst responsible for maintaining and gatekeeping the Nordic Hedge Index, and as a journalist covering the Nordic hedge fund industry for HedgeNordic. Eugeniu completed his Master’s degree at the Stockholm School of Economics in 2018. Write to Eugeniu Guzun at eugene@hedgenordic.com

Latest Articles

Opportunities Lie Beneath Aggregate Credit Spreads

Credit spreads across the United States and Europe have tightened to historically low levels, leaving limited reward for simply holding long credit positions. This...

European Alternative Investments Conference 2025

More than 200 practitioners, academics and thought leaders met in Copenhagen for the second European Alternative Investments Conference, hosted by Finansforeningen, CFA Society Denmark...

Playing ‘Moneyball’ for Investors

Having managed the opportunistic hedge fund Pensum Global Opportunities under the Pensum Asset Management umbrella since 2022, Sector co-founder Peter Andersland has now established...

One Big Winner Lifts Accendo Into the Top Ten

When your portfolio holds six names, one big winner can move the needle in a major way. For Accendo Capital, September proved just that....

Slim Nordic Line-Up at HFM Awards

With Intelligence has revealed the shortlist for the HFM European Performance Awards 2025, featuring an unusually small number of Nordic hedge funds among this...

Record Gold, Rising Momentum

The NHX CTA Index gained in September 2025, supported by a broad-based trend environment. Most of the profits came from precious metals, as gold...

Allocator Interviews

In-Depth: High Yield

Voices

Request for Proposal

- Advertisement -
HedgeNordic
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.